TD Cowen Issues Pessimistic Forecast for Danaher (NYSE:DHR) Stock Price

Key Points

• TD Cowen cut its price target on Danaher to $245 from $270 but kept a "buy" rating, a level that implies roughly a 24.24% upside from the stock's prior close.
• The consensus from analysts is a "Moderate Buy"—18 Buys and 3 Holds—with an average price target of about $247.35, though other firms' targets range from $225 to $275, showing mixed views.
• Danaher shares traded around $197.20, below analyst targets and its one‑year high of $242.80; the company recently beat EPS ($2.23 vs. $2.14) and revenue estimates (+4.6% YoY), while an executive disclosed a share sale and institutions own about 79% of the stock.

Danaher (NYSE:DHR - Get Free Report) had its target price decreased by equities research analysts at TD Cowen from $270.00 to $245.00 in a report issued on Monday,MarketScreener reports. The brokerage currently has a "buy" rating on the conglomerate's stock. TD Cowen's price objective would indicate a potential upside of 24.24% from the company's previous close.

Several other brokerages also recently weighed in on DHR. JPMorgan Chase & Co. increased their price target on shares of Danaher from $270.00 to $275.00 and gave the stock an "overweight" rating in a report on Thursday, January 29th. Wolfe Research dropped their price objective on shares of Danaher from $260.00 to $230.00 and set an "outperform" rating on the stock in a report on Wednesday, April 8th. Robert W. Baird set a $251.00 price objective on shares of Danaher in a research note on Thursday, January 29th. Leerink Partners boosted their target price on shares of Danaher from $260.00 to $270.00 and gave the company an "outperform" rating in a research report on Friday, January 16th. Finally, Evercore lowered their price target on shares of Danaher from $254.00 to $225.00 and set an "outperform" rating on the stock in a report on Monday, April 6th. Eighteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $247.35.

Danaher Stock Performance

Shares of DHR opened at $197.20 on Monday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The stock has a 50-day moving average of $200.48 and a two-hundred day moving average of $214.79. The stock has a market cap of $139.56 billion, a P/E ratio of 39.12, a P/E/G ratio of 2.57 and a beta of 0.95. Danaher has a one year low of $180.03 and a one year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts' consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. During the same period in the prior year, the company earned $2.14 earnings per share. The company's revenue was up 4.6% on a year-over-year basis. As a group, research analysts predict that Danaher will post 7.63 EPS for the current year.

Insider Buying and Selling

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the company's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the transaction, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. JPL Wealth Management LLC purchased a new stake in Danaher during the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter worth approximately $26,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Danaher during the third quarter worth approximately $27,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher in the 4th quarter valued at $27,000. Institutional investors and hedge funds own 79.05% of the company's stock.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.